Search our science

Search our scientific publications and resources
on rare bleeding disorders

Molecule
Study Phase
Content Type


Scientific resources from Novo Nordisk

Novo Nordisk supports sharing of the scientific research on our molecules. The search results below include peer-reviewed articles that are authored by Novo Nordisk employees or are funded by Novo Nordisk, as well as congress abstracts, posters and presentations, and also related educational resources.

 

Search Results

We found 359 resources matching your search criteria

Poster
Sun J, Xu W, Wu R, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Korsholm L, Matytsina I, Zhang S, Yang R. Successful haemostatic response and effective prophylaxis with turoctocog alfa in previously treated patients from China with severe haemophilia A (guardian 7). Research and Practice in Thrombosis and Haemostasis. 2019;3(Suppl. 1):265.
Abstract
Klamroth R, Feistritzer C, Friedrich U, Lentz SR, Reichwald K, Zak M, Chowdary P. Immunogenicity, safety, pharmacokinetics and preliminary efficacy results from the first human subcutaneous factor VIII trial (subcutaneous turoctocog alfa pegol, SC N8-GP) in previously treated patients with hemophilia A (alleviate 1). Res Pract Thromb Haemost. 2019;3(Suppl. 1):1-228.
Abstract
Sun J, Xu W, Wu R, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Matytsina I, Zhang S, Yang R. Successful haemostatic response during the treatment of bleeding episodes and effective prophylaxis with turoctocog alfa in previously treated patients from China with severe haemophilia A (guardian 7). Research and Practice in Thrombosis and Haemostasis. 2019;3(Supplement 1):265-266.
Primary manuscript
Curry N, Albayrak C, Escobar M, Holme PA, Kearney S, Klamroth R, Misgav M, Negrier C, Wheeler A, Santagostino E, Shima M, Landorph A, Tønder SM, Lentz S. Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial). Haemophilia. 2019;25(3):373-381.
Abstract
Croteau S, Cutter S, Hernandez G, Wicklund B, Dreyer Gillette M, Haugstad K, Cooper D, Ostrow V, Nadglowski J. Awareness, Care, and Treatment in Obesity Management to inform Hemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): Results of a survey of United States (US) Patients with Hemophilia and Obesity (PwHO) and their Partners and Caregivers. Hemostasis & Thrombosis Research Society - 2019 Scientific Symposium. 2019.
Abstract
Wang M, Peltier S, Baumann K, Sidonio R, Wadden T, Witkop M, Cooper D, Waters E, Kahan S. Awareness, Care, and Treatment in Obesity Management to inform Hemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): Results of a survey of United States (US) Hemophilia Treatment Center (HTC) Professionals. Hemostasis & Thrombosis Research Society - 2019 Scientific Symposium. 2019.
Poster
Croteau S, Cutter S, Hernandez G, Wicklund B, Dreyer Gillette M, Haugstad K, Cooper D, Ostrow V, Nadglowski J. Awareness, Care, and Treatment in Obesity Management to Inform Hemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): A Survey of US Patients with Hemophilia and Obesity and their Partners and Caregivers. Hemostasis & Thrombosis Research Society - 2019 Scientific Symposium. 2019.
Poster
Wang M, Peltier S, Baumann K, Sidonio R, Witkop M, Cooper D, Waters E, Kahan S. Awareness, Care, and Treatment in Obesity Management to Inform Hemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): Results of a Survey of United States Hemophilia Treatment Center Professionals. Hemostasis & Thrombosis Research Society - 2019 Scientific Symposium. 2019.
Secondary manuscript
Kearney S, Raffini LJ, Pham TP, Lee XY, von Mackensen S, Landorph A, Takedani H and Oldenburg J. Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII. Patient Prefer Adherence. 2019;2019(13):497-513.
Review article
Casas Patarroyo CP, del Pilar Agudelo López C, Galvez K, Ibarra JL, Rojas SM, Bernal LI. Importancia de la orientación diagnóstica en hemofilia A adquirida (Adequate diagnosis of acquired hemophilia A). Rev Med Chil. 2019;147(3): 334-341.

This website is intended
for healthcare professionals (HCPs)
outside of the U.S.

Take me to www.novonordisk.com